1Bickel C, Rmpprecht HJ, Blankenberg S, et al. Relation of markers of inflammation ( C-reactive protein, fibrinogen, yon Willebrand factor,and lemkocyte comnt)and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol,2002,89(8) :901-908.
2Bhagat S, Gaiha M, Sharma VK, et al. A comparative evalmation of C-reactive protein as a short-term prognostic marker in severe mnstable angina-a preliminary stmdy. J Assoc Physicians India,2003,51 : 349-354.
3Ridker PM. Clinical application of C-reactive protein for cardiovascmlar disease detection and prevention. Circmlation, 2003, 107: 369-371.
2TORZEWSI J, TORZEWSKI M, BOWYER D F, et al. C-reactive Protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J].Arterioacler Thromb Vasc Biol, 1998, 18: 1386-1392.
3HOFFMEISTER H M, EHLERS R, BUTTTTCHER E,et al. Comparison of C-reactive Protein and terminal complement complex in Patients with unstable angina Pectoris versus stable angina pectoris [J]. Am J Cardiol,2002,89:909- 912.
4RIDKER P M ,CUSHMAN M ,STEMPFER M J, et al. Infammation aspirin and the risk of cardoivascular diseases in apparently healthy men [J]. N Engl J Med, 1997,336 :973-979.
5MORISHIGE K, SHIMOKAWA H, MATSUMOTO Y, et al. Overexpression of matrixmetalloproteinase-9 promotes intravaseular thrombus formation in porcine coronary arteries in vivo [J]. Cardiovase Res, 2003,57:572-85.
6BROWN D L, HIBBS M S, KEARNEY M, et al. Identifieation of 92-kD gelatinase in human coronary atheroselerotie lesions. Association of active enzyme synthesis with unstable angina [J]. Circulation,1995,91 :2125-2131.
7SHAH P K, FALK E, BADIMON J J, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture [J]. Circulation,1995,92:1565- 1569.
8KAI H, IKEDA H, YASUKAWA H, et al. Peripheral blood levels of matrix metalloproteases-2 and-9 are elevated in parients with acute coronary syndromes[J]. J Am Coll Cardiol, 1998,32 : 368- 372.
9HOJO Y, IKEDA U, UENO S, et al. Expression of matrix metalloproteinases in patients with acute myocardial infarction [J]. Jpn Circ J, 2001,65:71 - 75.
10BLANKENBERG S, RUPPRECHT H J, POIRIER O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease[J]. Circulation,2003,107: 1579- 1585.
